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Abstract: Hyperbaric oxygen therapy at 2.4 atmospheric pressure absolutes for 90 minutes 
per day ameliorated the signs and symptoms of agitation, confusion, and emotional distress in 
a 27-year-old male seven days following a traumatic accident. Hyperbaric oxygen was used to 
treat the patient’s crush injury and underlying nondisplaced pelvic fractures which were sus-
tained in a bicycle versus automobile traffic accident. Its effect on the patient’s neuropsychiatric 
symptoms was surprising and obvious immediately following the initial hyperbaric oxygen 
treatment. Complete cognitive and psychiatric recovery was achieved by the seventh and final 
hyperbaric oxygen treatment. We propose that hyperbaric oxygen was effective in improving 
the patient’s neuropsychiatric symptoms by reducing cerebral oxidative stress, inflammation, 
vasogenic edema, and hippocampal neuronal apoptosis. Further investigation into the use of 
hyperbaric oxygen as a novel therapy for the secondary prevention of post-traumatic stress 
disorder that often accompanies postconcussive syndrome may be warranted. We acknowledge 
that hyperbaric oxygen therapy has been shown to have a strong placebo effect on neurologic 
and psychiatric diseases.
Keywords: hyperbaric oxygen, post-traumatic stress disorder, neuropsychiatric, acute stress 
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Introduction
Post-traumatic stress disorder (PTSD) is a global problem that continues to grow as 
our understanding and use of simple explosive chemistry becomes more prevalent. The 
general population is now beginning to view PTSD as more of a public health concern, 
largely because the media has increased their focus on the impact that PTSD has on 
military personnel returning to the US from service in Iraq. In the civilian popula-
tion, PTSD following motor vehicle accidents, the most common cause of PTSD, is 
less likely to be recognized by the general population and medical community than 
PTSD caused by exposure to military combat.1,2 Research and evidence related to the 
pathogenesis of PTSD suggests that the dysfunction is not merely present in the mind, 
but that organic changes in the hippocampus and limbic system are also involved.2–4 
Humans are regularly exposed to painful or difficult situations, and manageable stress 
is considered to play a positive role in our lives. However, uncontrollable stress is the 
primary etiologic factor in the development of acute stress disorder and PTSD.2
Acute stress disorder and PTSD are the same constellation of symptoms involv-
ing intense fear, sleep abnormalities, behavioral changes, and intrusive thought 
processes that may develop following exposure to a life-threatening event. The 





disorder and greater than one month in acute PTSD as per 
the Diagnostic and Statistical Manual of Mental Disorders, 
fourth edition (DSM-IV) criteria. Because PTSD has been 
shown to be particularly difficult to treat and has a profound 
negative impact on the affected patient’s quality of life, it 
is important to recognize the signs and symptoms early in 
at-risk patients in order to attempt to stop progression from 
acute stress disorder to PTSD. Several studies have shown 
hyperbaric oxygen therapy to be effective in preventing or 
treating acute psychiatric disturbances that are associated 
with stress and disease.4,5
We suggest that it is reasonable to investigate if hyper-
baric oxygen therapy is an effective modality for treating 
acute stress disorder and if it may serve potentially as second-
ary prevention of PTSD in patients who have experienced 
life-threatening trauma resulting in crush injuries because 
these victims of trauma are at increased risk for developing 
PTSD, and hyperbaric oxygen is an indicated therapy for 
their crush injuries.6,7 Hyperbaric oxygen therapy has been 
used with varying degrees of success in treating chronic 
psychiatric and neurologic diseases and is currently being 
investigated for the potential treatment of autism, multiple 
sclerosis, and chronic traumatic brain injury.8 Acute neuro-
logic and psychiatric disturbances such as acute traumatic 
brain injury, lacunar infarcts, acute stress disorder, and acute 
PTSD may respond better than chronic neurologic and psy-
chiatric conditions to hyperbaric oxygen therapy.
Currently eight of the 13 disorders that hyperbaric oxygen 
is approved for treating are acute conditions.6,9–12 There is 
strong evidence that hyperbaric oxygen therapy decreases 
vasogenic edema and inflammation in soft tissue injuries.6 
The mechanisms involved for hyperbaric oxygen treating soft 
tissue injuries are related to the extreme elevations in tissue 
oxygen tensions generated under supra-atmospheric oxygen 
pressures and are discussed further in this report. Because the 
brain is an electrical organ and its functional networks and 
supportive structures are made up of different cells than soft 
tissues, the mechanisms involved in treating nervous tissue 
with hyperbaric oxygen are probably also different but may 
act similarly.13,14
Case report
A fit 27-year-old male presented to the hyperbaric oxygen 
department in pain and emotional distress seven days follow-
ing a traumatic accident. His appeared agitated and reported 
that his symptoms of confusion, intense fear, and intrusive 
thoughts of the accident were becoming worse each day. The 
trauma occurred when the patient was cycling through a 
traffic intersection and was hit directly in the left hip by a 
car traveling at approximately 30 miles/hour. The collision 
displaced the patient from his bicycle. His left shoulder 
impacted and shattered the driver’s side windshield. His 
body continued to roll over the automobile and was launched 
into the air with a trajectory perpendicular to the vector of 
the automobile. The patient landed on the road 15 feet away 
from the site of impact.
Following the trauma, the patient reported a transient 
loss of consciousness. He was alert, oriented, responded to 
questions appropriately, and there were no focal neurologic 
deficits on physical examination. The patient was able to 
move all four of his extremities. However, he reported 
severe pain in his left hip upon movement. He was highly 
agitated and expressed himself with strong emotional lan-
guage at the scene. Computed tomography (CT) of the head 
was unremarkable. The only abnormal X-ray finding was a 
small avulsion fracture of the ankle. The patient’s pain in the 
emergency department at rest was controlled with 60 mg of 
ketorolac intramuscularly and two tablets of paracetamol 
three times a day orally. The following day, magnetic reso-
nance imaging (MRI) of the patient’s left hip, pelvis, and 
lumbar spine was performed to look for orthopedic injuries 
because the patient had a considerable amount of pain with 
limb movement. MRI of the left hip and pelvis were positive 
for a large left flank hematoma, several pelvic fractures, and 
a femoral head contusion.
The patient began experiencing frequent episodes of cry-
ing on the day of the accident. He reported recurrent intrusive 
thoughts which were described as “attempts to piece together 
or find the details that were missing from the time of being 
hit until landing in the road”. He experienced insomnia 
associated with nightmares and became progressively more 
fearful each day following the accident. On the fourth day 
he initiated the process of re-exposing himself to the stress-
ful situation by riding another bicycle through the streets of 
Chicago. The patient reported that he was worried that he 
was experiencing signs and symptoms of PTSD and felt as 
if he were losing control and did not know what to do.
Prior to the event the patient had not experienced any 
significant trauma. His medical history was only positive for 
seasonal allergies for which he occasionally took loratadine. 
The patient did not have a psychiatric history and denied 
tobacco, alcohol, and drug use. His family history was posi-
tive for breast cancer in his mother and hypertension in his 
father; there was no family history of psychiatric illness. In 
spite of having a clean medical and psychiatric history our 
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stress disorder and PTSD, ie, sustained accompanying physi-
cal injury, a manmade life-threatening event, and a strong 
emotional reaction to the traumatic event.
Hyperbaric oxygen therapy was initiated to treat the 
patient’s crush injury. After the first hyperbaric oxygen 
treatment, the patient appeared remarkably less agitated 
upon exiting the chamber, displayed an appropriate state of 
arousal, and appeared calm. He reported that his sense of 
security had returned and that he was able to sleep comfort-
ably without nightmares. The patient’s episodes of crying had 
also resolved. By the seventh treatment, the patient was free 
from all psychiatric and cognitive symptoms. A psychiatric 
evaluation and scoring by the clinician-assessment PTSD 
scale confirmed that the patient was experiencing worsening 
signs and symptoms of acute stress disorder and that they 
resolved promptly with hyperbaric oxygen therapy.
Discussion
We acknowledge that our patient’s psychiatric disturbance 
would have most likely resolved spontaneously without 
hyperbaric oxygen therapy with more time, because most 
cases of acute stress disorder do not progress into PTSD. 
However, our patient’s symptoms of confusion and agitation 
were markedly reduced upon his removal from the hyperbaric 
chamber following the initial treatment. Because hyperbaric 
oxygen treatment has been shown to have a strong placebo 
effect on neurologic and psychiatric diseases it is possible 
that his condition improved because of the simple expectation 
of feeling better with treatment.15 However, in our case it is 
not likely that the placebo effect played a significant role in 
improving our patient’s cognitive and psychiatric symptoms 
because the patient only expected his pelvic injury to improve 
from hyperbaric oxygen therapy. It is also possible that 
the effect was because of the pain relief which hyperbaric 
oxygen treatment provided. Despite the limitations of the 
study we believe our case is significant because our patient’s 
fear, emotional distress, and agitation were progressively 
worsening each day post-trauma until the initial hyperbaric 
oxygen treatment.
Cerebral CT scan in the emergency department was 
ordered to exclude the possibility of a life-threatening head 
injury, such as a subdural hemorrhage, which could be 
missed clinically if the presenting symptoms were subtle. 
Because the patient did not complain of a headache and 
focal neurologic abnormalities were not observed during 
neurologic examinations, MRI of the brain was not ordered 
by any of the physicians who cared for the patient. Cerebral 
MRI, magnetic resonance angiography, magnetic resonance 
spectroscopy, or noninvasive optimal blood flow analysis 
may have shown subtle findings consistent with the patient’s 
history such as vasogenic edema, diffuse axonal injury, or 
alteration in cerebral blood flow.16,17 Highly sophisticated 
cerebral imaging will likely play a crucial role, serving as 
an objective assessment of the efficacy of hyperbaric oxygen 
in treating neuropsychiatric disorders following traumatic 
injury as more studies are completed.16–19
The pharmacologic mechanisms of hyperbaric oxygen 
therapy appear to work against more than one pathophysi-
ologic process. We propose that the overall therapeutic 
effect of hyperbaric oxygen therapy on acute traumatic 
neuropsychiatric dysfunction is to reduce vasogenic edema 
and limit hippocampal dysfunction.20–24 Following traumatic 
neurologic injury, it is important to achieve optimal clearing 
of the proinflammatory cytokine storm associated with acute 
central nervous system injury. It is well known that reducing 
cerebral vasogenic edema improves neurologic outcomes fol-
lowing trauma. Oxidative stress and inflammation together 
disturb laminar blood flow by altering macrophages and 
T lymphocyte function which results in cell accumulation 
and adherence to the endothelium.6,7,11,12 Hyperbaric oxygen 
therapy generates tremendous tissue oxygen tensions which 
reverse in vivo electrochemistry to a reductive state and has 
been shown to prevent cerebral lipid peroxidation following 
carbon monoxide exposure.11,25–27 The anti-inflammatory 
effects of hyperbaric oxygen may involve reduction of 
glutathione and suppression of tumor necrosis factor-α, 
interleukin-6, and tissue myeloperoxidase.20,28
Damage to the hippocampus and limbic system appears 
to be important in the development of PTSD, the postcon-
cussive syndrome, and postdepressive syndromes.20,21,24 The 
hippocampus is uniquely positioned among the vascular 
territories of the posterior cerebral artery, anterior cerebral 
artery, anterior choroidal artery (a branch of the internal 
carotid artery), and penetrating branches of the middle 
cerebral artery.25 The rich collateral blood flow to the hip-
pocampus and limbic region is a therapeutic target. Damage 
to the surrounding microvasculature and endothelium in the 
injured tissue increases capillary permeability and displaces 
fluid to the interstitial space. Increased interstitial osmotic 
pressures force fluid into surrounding cells which results 
in concomitant intracellular edema.12,24 Intra- and extracel-
lular edema together promote hypoxia, cell death, and tissue 
  ischemia. Hyperbaric oxygen therapy counteracts the 
vasogenic edema complex of edema, hypoxia, and vasodila-
tion by acting as a robust vasoconstrictor.7,12 Vasoconstric-





reverses the hydrostatic   pressure gradient to favor lymphatic 
and microvasculature fluid reabsorption. Reducing vasogenic 
edema improves venous outflow and ultimately restores 
functional vascular flow.6
Damage to the hippocampus has been repeatedly impli-
cated as a causal factor in the development of PTSD, the post-
concussive syndrome, and postdepressive syndromes.13–15,25,26 
PTSD is associated with hippocampal atrophy in humans.21,22 
A proposed mechanism for the hippocampal dysfunction 
involves the activation of mitochondrial apoptotic pathways 
mediated via pathophysiologic crosstalk elements, ie, reac-
tive oxygen species, cytochrome c, and caspases.19,24 Expos-
ing rats to a single prolonged stress, a proposed method for 
inducing PTSD in animals, reproducibly kills hippocampal 
neurons via apoptosis.26,27 Preconditioning rats with induced 
PTSD using hyperbaric oxygen prevented the loss of hip-
pocampal neurons by inhibiting mitochondrial apoptotic 
pathways. Hyperbaric oxygen preconditioning also improved 
the animals’ neurologic and behavioral outcomes.26,27 Pre-
conditioning with hyperbaric oxygen has also been shown 
to reduce postpump depression significantly following 
cardiopulmonary bypass.13,14 Directing therapy to serve as 
secondary prevention of PTSD for at-risk patients or patients 
with early cognitive and psychiatric disturbances following 
trauma may be useful. There is recent evidence suggesting 
that the use of morphine in acute trauma care may reduce 
the risk of developing PTSD following serious injury by 
blocking memory consolidation mediated via adrenergic 
pathways.29
Conclusion
Several other case studies have been reported in which 
hyperbaric oxygen therapy resulted in a dramatic reduction 
or abolition of psychiatric symptoms in individuals suffering 
from postconcussive syndrome with and without associated 
PTSD features.17,30,31 Remarkably, hyperbaric oxygen therapy 
was effective in eliminating psychiatric symptoms when 
initiated six months to three years post-trauma. We report 
the first case of hyperbaric oxygen ameliorating the signs and 
symptoms of acute stress disorder following a life-threatening 
traumatic injury. We suggest that hyperbaric oxygen therapy 
was effective in improving our patient’s acute psychiatric 
disturbance by effectively counteracting the pathologic 
processes of oxidative stress, acute inflammation, vasogenic 
edema, and hippocampal neuronal apoptosis. Our case may 
support further investigation into the use of hyperbaric oxy-
gen therapy as a novel treatment for the secondary prevention 
of PTSD and postconcussive syndromes.29,32
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